newsfilter
← Latest News
GlobeNewswire·

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

  • iBio, Inc. (NASDAQ: IBIO) announced participation in the Wells Fargo 21st Annual Healthcare Conference on September 8-10, 2026, in Boston.
  • CEO Martin Brenner, DVM, Ph.D., will lead a fireside chat on Tuesday, September 8, at 4:30 p.m. ET.
  • A livestream of the presentation is available online, with a replay accessible via the Investor Relations section of the iBio website for 90 days post-event.
  • CFO Felipe Duran will join Dr. Brenner for one-on-one investor meetings during the conference.
  • Investors can request meetings with Dr. Brenner or Mr. Duran by contacting ir@ibioinc.com.
  • iBio is a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic, cardiopulmonary diseases, cancer, & other hard-to-treat conditions using AI-driven discovery.
  • Investor relations contact is Ignacio Guerrero-Ros, Ph.D., or David Schull at Russo Partners, LLC, via email or phone at (858) 717-2310 or (646) 942-5604.